Showing results (1741-1750 of 4,380) with videos related to

Sort By:
Pageof 438
ACS Medicinal Chemistry Letters|June 6, 2014
Potent and Selective Inhibitors of CK2 Kinase Identified through Structure-Guided HybridizationJames E Dowling, Claudio Chuaqui, Timothy W Pontz, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Stimulation of Glucose-Dependent Insulin Secretion by a Potent, Selective sst3 AntagonistAlexander Pasternak, Zhe Feng, Reynalda de Jesus, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
An Orally Available 3-Ethoxybenzisoxazole Capsid Binder with Clinical Activity against Human RhinovirusSusanne C Feil, Stephanie Hamilton, Guy Y Krippner, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Inventorship and ownership considerations and pitfalls with collaborative research: patent highlightMaryAnne Armstrong, Gerald M Murphy
ACS Medicinal Chemistry Letters|June 6, 2014
Drug repurposing and the medicinal chemistJeffrey Aubé
ACS Medicinal Chemistry Letters|June 6, 2014
Fragment-Based Discovery of 7-Azabenzimidazoles as Potent, Highly Selective, and Orally Active CDK4/6 InhibitorsYoung Shin Cho, Hayley Angove, Christopher Brain, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Synthesis and biochemical evaluation of thiochromanone thiosemicarbazone analogues as inhibitors of cathepsin LJiangli Song, Lindsay M Jones, G D Kishore Kumar, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of HDAC Inhibitors That Lack an Active Site Zn(2+)-Binding Functional GroupChris J Vickers, Christian A Olsen, Luke J Leman, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Biotin analogues with antibacterial activity are potent inhibitors of biotin protein ligaseTatiana P Soares da Costa, William Tieu, Min Y Yap, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Design and synthesis of potent, selective inhibitors of matriptaseEloïc Colombo, Antoine Désilets, Dominic Duchêne, et al.
Pageof 438